In the early stages of DM, blocking the bradykinin-1 receptor is associated with decreased leukostasis, hypoxia-inducible factor (HIF)-1α expression, vascular endothelial growth factor (VEGF) expression, and vascular permeability (45, 46). The gene discussed is BDKRB1; the disease is diabetes mellitus.